Atipamezole hydrochloride (Ref: NSC 71310) |
Last updated: 21/05/2024 |
(Also known as: atipamezole HCl) |
|
|
A veterinary drug for the reversal of the sedative effects and cardiovascular effects following application of certain drugs | |
---|---|---|
|
Current | |
|
1996, first US approval | |
|
Used to reverse the sedative and analgesic effects of the drugs dexmedetomidine and medetomidine. | |
|
Dogs; Cats; Elephants; Bears; Ferrets; Apes |
Approval status |
|
Approved | |
---|---|---|
|
Approved |
Chemical structure |
|
- | |
---|---|---|
|
C₁₄H₁₇ClN₂ | |
|
CCC1(CC2=CC=CC=C2C1)C3=CN=CN3.Cl | |
|
- | |
|
PCCVCJAQMHDWJY-UHFFFAOYSA-N | |
|
InChI=1S/C14H16N2.ClH/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14;/h3-6,9-10H,2,7-8H2,1H3,(H,15,16);1H | |
|
Yes |
|
Common Name | Relationship | Link |
---|---|---|
atipamezole hydrochloride | Parent |
General status |
|
Sedative antidote | |
---|---|---|
|
Unclassified substance | |
|
- | |
|
- | |
|
Synthetic | |
|
Alpha2 adrenergic receptor antagonist which selectively and competitively inhibits alpha2-adrenergic receptors | |
|
[Alpha-2 adrenergic receptor, Antagonist] | |
|
13649426 | |
|
- | |
|
- | |
|
- | |
|
- | |
|
Antidotes: Atipramezole | |
|
QV03AB90 | |
|
No | |
|
- | |
|
248.75 | |
|
- | |
|
5-(2-ethyl-1,3-dihydroinden-2-yl)-1H-imidazole; hydrochloride | |
|
- | |
|
- | |
|
- | |
|
Crystalline solid |
Formulations |
|
|
|
|
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Antisedan | Orion Corps | UK National authorisation | Prescription only medicine to be authorised by a veterinarian (POM-V) | ||||||
Sedastop 5 solution for injection | Le Vet B.V. | GB National Authorisation | Prescription only medicine to be authorised by a veterinarian (POM-V) | |||||||
Antipam 5.0 mg/ml solution for injection | Eurovet Animal Health B.V. | GB National Authorisation | Prescription only medicine to be authorised by a veterinarian (POM-V) | |||||||
Revertor 5 mg/ml solution for injection | CP Pharma | GB National authorisation | Prescription only medicine to be authorised by a veterinarian (POM-V) | |||||||
|
Formulated as a solution for injection |
|
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 50 | P3 P = Other non-EU, UK or US Governments and Regulators Rat3 = Unverified data of known source |
High | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | - | - | |||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
> 50 | P3 P = Other non-EU, UK or US Governments and Regulators Rat3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
Subcutaneous TDLo = 0.1 mg kg⁻¹ | R3 R = Peer reviewed scientific publications Rat3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Metabolised in the liver and rapidly (2-3 hrs) eliminated in urine. | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
May cause cardiovascular effects Possible CNS toxicant |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Not compatible with strong oxidising agents Will release toxic gases if heated to decomposition |
|||
|
Health: H301, H311, H331 | |||
|
Not listed (Not listed) | |||
|
None allocated | |||
|
- | |||
|
- |
|
|
|
||
---|---|---|---|
|
atipamezole hydrochloride | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 21/05/2024 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |